Catalyst
Slingshot members are tracking this event:
Alder (ALDR) Announces Positive Results from Phase 1 Study Evaluating Quarterly Self-Administration of ALD403 in Chronic Migraine Patients
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALDR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 28, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Intravenous, Subcutaneous, Intramuscular, Phase 1 Study, Self Administration, Ald403
